Onward Assist’s clinical collaborations with cancer institutes are focused on novel approaches, challenges faced in cancer prognostics and important biomarkers. The platform uses machine learning expertise to build a portfolio of diagnostic tools in the form of classifiers and analytical tools. They establish clinical partnerships with diagnostic labs based on the match between the tools and the clinical workflow of the diagnostics provider. These labs bring in clinical expertise, exposure to real-world challenges, as well as validate the tools. In most cases, there needs to be 1-2 areas where the tools they build will be of significant value to the partner, in terms of productivity or for extending the clinical service beyond an existing network. They also work with leading pathologists, radiologists as well as oncologists to build machine learning (ML) models. The clinicians look at the base diagnostic and scoring tools and help identify the areas in which they can leverage the tools. They also work together in identifying additional features that could be added to the tool to improve its utility and effectiveness. Moreover, Onward Health provides tools in computational pathology and mammography, leveraging computer vision techniques and ML algorithms.
